Q-VANT team is capable to support the vaccine developers and manufacturers throughout the entire vaccine development life cycle.
TPP / Basic Research
Discovery / Feasibility
Preclinical / Early Phase
Clinical / Late Phase
Manufacturing
Regulatory Approval
Distribution
Scientists
Francisco Ibañez, Ph.D.
Vaccine and Adjuvant Specialist Developer
Biochemist specialized in immunology with vast academic and professional experience in the development of antiviral drugs, vaccines against respiratory viruses, and adjuvants.
Elias Atala, Ph.D.
Technology Manager
Expert in chromatographic process development with 10 years of experience in R&D chemistry, purification and application of quillaja saponins.
Manufacturing
Hans Konsens
Chief Operating Officer
More than 10 years of experience in quillaja extract process development, supply chain, manufacturing, R&D and commercialization. Former Founder and Managing Director of Chile Botanics–Naturex, global leader in the Quillaja Extracts markets.
Cristobal Silva
Manufacturing engineer
Biotechnologist, expert in the industrial field of botanical extracts including purification, analytical quantification and product formulation.
Regulatory & Quality
Jack Love, Ph.D.
VP of Regulatory Affairs
Former AVP Regulatory Affairs for Pfizer Vaccines. More than 25 years of pharmaceutical experience including new vaccine development and regulatory approvals.
Vannia Delgado
Quality & Regulatory Manager
More than 10 years of experience in quality management in the pharmaceutical industry.
Business & Administration
Doug Klaiber
Chief Executive Officer
More than 25 years of start-up, technology and pharmaceutical experience. Former CEO of Decas Botanical Synergies and Naturex-DBS.
Juan José Albarrán
Chief Commercial Officer
More than 10 years of experience in quillaja extract process development, supply chain, manufacturing, R&D and commercialization. Former Founder and Managing Director of Chile Botanics–Naturex, global leader in the Quillaja Extracts markets.
Stein Lokstad
VP of Business Development
Former GM of Brenntag Biosector vaccine adjuvant company. More than 25 years pharmaceutical experience including 10 years developing and selling vaccine adjuvants.
Matthieu Privat
Business Development Manager
More than 10 years of experience in molecular biology and quillaja saponin marketing, supply chain. Former Deputy Commercial Manager of Desert King.
